Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:focus |
gptkb:COVID-19
|
| https://www.w3.org/2000/01/rdf-schema#label |
Solidarity trial
|
| gptkbp:organizedBy |
gptkb:World_Health_Organization
|
| gptkbp:participants |
over 30 countries
|
| gptkbp:purpose |
test treatments for COVID-19
|
| gptkbp:relatedTo |
gptkb:COVID-19_pandemic
|
| gptkbp:result |
no significant effect on mortality for tested drugs
|
| gptkbp:resultPublicationDate |
October 2020
|
| gptkbp:startDate |
March 2020
|
| gptkbp:status |
ongoing
|
| gptkbp:studiedDrug |
gptkb:lopinavir/ritonavir
gptkb:remdesivir gptkb:interferon_beta-1a hydroxychloroquine |
| gptkbp:type |
international clinical trial
|
| gptkbp:website |
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
|
| gptkbp:bfsParent |
gptkb:Remdesivir_(COVID-19_treatment)
|
| gptkbp:bfsLayer |
6
|